1. Home
  2. Analysis
  3. Superinvestors
Superinvestors

Prem Watsa's Q3 13F: Equinox Gold Hits 25% as Fairfax Bets 44% on Gold Miners

Fairfax Financial's Q3 13F reveals a $2.6B book dominated by a 44% gold miner stake after the Equinox-Orla merger, with a new buy in Coty and additions to Pfizer.

BMInsider desk · · 3 min read

Prem Watsa's Fairfax Financial filed its third-quarter 13F on Monday, Nov. 16, revealing an unchanged $2.6 billion U.S. equity portfolio marked by a massive consolidation in the gold mining sector. For investors tracking the Canadian value manager, the filing shows an extraordinary degree of concentration, with just two precious metal producers now commanding over 44% of Fairfax's public U.S. stock holdings.

What happened

The most striking headline from the filing is the sudden appearance of Equinox Gold (EQX) as Fairfax's number one position at 24.51% of the portfolio, while former core holding Orla Mining (ORLA, previously 21.55%) was completely eliminated. Rather than an outright divestment, this shift reflects the July 31, 2026, completion of Equinox Gold’s all-stock acquisition of Orla Mining, where Orla shares were exchanged one-for-one for Equinox shares alongside the conversion of $150 million in Fairfax-held convertible notes.

Combined with an untouched 19.89% position in Eldorado Gold (EGO), gold miners now make up a staggering 44.40% of Fairfax's 34 reported equity holdings.

Beyond the gold merger, Prem Watsa initiated several new positions during the quarter. The largest fresh purchase was cosmetics maker Coty (COTY), entering the portfolio at 0.75% with a value of roughly $19.95 million. Fairfax also initiated minor starter stakes in Uber Technologies (0.09%), International Money Express (0.09%), equipment rental group Sunbelt Rentals (0.09%), and apparel maker Gildan Activewear (0.05%).

Watsa also selectively boosted existing consumer and healthcare stakes. Fairfax expanded its holding in brewer Molson Coors Beverage (TAP) by 15% in share count, lifting the position to 3.16% of reported assets. The firm also increased its shares in pharmaceutical giant Pfizer (PFE) by 36%, bringing its weighting to 1.53%.

Apart from the structural elimination of Orla Mining, complete exits were modest: Fairfax liquidated its residual positions in Johnson & Johnson (previously 0.71%), Electronic Arts (0.04%), and Peruvian building materials supplier Cementos Pacasmayo (0.02%). Longstanding anchor positions remained entirely unchanged, including Kraft Heinz (12.27%), CVS Health (8.78%), Under Armour (7.64% in Class A and 3.61% in Class C), and Cleveland-Cliffs (6.20%).

Why it matters

Form 13F filings reflect U.S.-listed long equity holdings as of September 30 with a 45-day reporting lag, excluding cash, debt securities, and foreign listings, while option holdings are reported at the aggregate value of the underlying rather than the capital at risk. For Prem Watsa, whose broader firm oversees nearly $79 billion in total invested assets, the $2.6 billion 13F report captures only a focused segment of Fairfax’s total balance sheet.

Yet within this public equity window, the allocation choices stand in stark contrast to conventional Wall Street diversification. While broader markets remain heavily exposed to technology valuations, Watsa is running an aggressive macro barbell: heavy exposure to tangible resources and defensive, cash-generative consumer staples.

The combined 44.4% weight in Equinox Gold and Eldorado Gold underscores Fairfax's conviction in commodities and gold as long-term hedges against currency debasement and geopolitical friction. By backing Equinox's absorption of Orla, Fairfax helped build a senior gold producer with multi-asset Canadian production scale. Simultaneously, adding to high-yielding, beaten-down value names like Molson Coors and Pfizer reveals Watsa’s continuing preference for low earnings multiples and steady cash generation over growth momentum.

What to watch next

  • Equinox Gold operational delivery: Integration progress across the combined Canadian and Latin American asset base, specifically production ramp-ups and all-in sustaining cost (AISC) control at the Greenstone and Valentine mines.
  • Gold margin translation: How effectively sustained gold prices convert into debt reduction and free cash flow across Fairfax's top two mining holdings.
  • Consumer anchor turnarounds: Operational performance and margin stability at core holdings Kraft Heinz, CVS Health, and Under Armour through the peak holiday shopping season.
  • Follow-through on starter positions: Whether fourth-quarter filings in mid-February 2027 show further capital deployed into newly initiated names like Coty and Sunbelt Rentals.

Stocks in this analysis

AI stock analysis

Free on aktienanalyse.ai: score profile, ratios versus the industry and business model. Plus, if you want it, the full analysis with fair value and bull, base and bear case. Prices and ratios as of Nov 16, 2026.

Sources (3)
  1. SEC EDGAR Form 13F: Fairfax Financial Holdings Ltd / Prem Watsa (Q3 2026)
  2. Equinox Gold Corp. and Orla Mining Ltd. Arrangement Agreement and Closing
  3. Fairfax Financial Holdings Limited Q3 2026 Financial Results

This analysis is for information only and is not investment advice. Prices and figures as of publication.

AI stock analysis

Any stock analysed in minutes

Business model, balance sheet, valuation and scenarios: aktienanalyse.ai builds a thorough analysis of any stock in minutes, with a fair value and bull, base and bear cases.

Analyse a stock → Stock profiles